Plunkett Research Online: Astellas Gene Therapies

ASTELLAS GENE THERAPIES (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Astellas Gene Therapies, formerly Audentes Therapeutics, Inc. is a biotechnology company committed to the development and commercialization of innovative adeno-associated viral vector (AAV)-based genetic medicines. The firm operates in three divisions: gene therapy research and technical operation.....


ASTELLAS GENE THERAPIES

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 415-818-1001
Fax:
Address: 600 California St., Fl. 17
San Francisco, CA 94108 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Astellas Pharma Inc

Contacts Description

Nathan Bachtell Sr. VP/Head-Gene Therapy
Thomas Soloway CFO/Chief Accounting Officer/Executive VP
See More
Astellas Gene Therapies, formerly Audentes Therapeutics, Inc. is a biotechnology company committed to the development and commercialization of innovative adeno-associated viral vector (AAV)-based genetic medicines. The firm operates in three divisions: gene therapy research and technical operation.....See More See More

$USD, In whole numbers 2019 2018 2017 2016 2015 2014 2013
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture